2.7(top 8%)
Impact Factor
3(top 8%)
extended IF
99(top 3%)
H-Index
3.9K
authors
8K
papers
133.9K
citations
5.5K
citing journals
50.4K
citing authors

Most Cited Articles of Leukemia Research

TitleYearCitations
Diagnostic criteria and classification of mastocytosis: a consensus proposal2001871
Establishment of an immature mast cell line from a patient with mast cell leukemia1988645
Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI2003409
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference2007393
A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells1984315
1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells1983275
Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy2001266
In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy2009251
Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H1998238
Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT)2007237
A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors1985230
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients2000225
Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells1984215
Human CD38: a (r)evolutionary story of enzymes and receptors2001212
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review2010208
HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells2006204
Hematopoietic-specific microRNA expression in human cells2006203
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation1999200
Properties and usefulness of the original K-562 human myelogenous leukemia cell line1979199
The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells1994197
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings2001185
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria2003184
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis2001184
Phenotypic heterogeneity and cellular origins of T cell malignancies1981177
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis2009173